5-Bromoacenaphthene → (3R)-1-(1,2-Dihydro-5-acenaphthylenyl)-3-methylpiperazine
反応式
[CH3:1][C@@H:2]1[CH2:7][NH:6][CH2:5][CH2:4][NH:3]1.C1(P(C2C=CC=CC=2)C2C=CC3C(=CC=CC=3)C=2C2C3C(=CC=CC=3)C=CC=2P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.CC(C)([O-])C.[Na+].Br[C:61]1[C:71]2[C:72]3[C:64]([CH2:65][CH2:66][C:67]=3[CH:68]=[CH:69][CH:70]=2)=[CH:63][CH:62]=1>C1(C)C=CC=CC=1.ClCCl.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[CH2:65]1[C:64]2=[C:72]3[C:71](=[CH:61][CH:62]=[CH:63]2)[C:70]([N:6]2[CH2:5][CH2:4][NH:3][C@H:2]([CH3:1])[CH2:7]2)=[CH:69][CH:68]=[C:67]3[CH2:66]1参加物
8
反応物 4
生成物 1
試薬・触媒・溶媒 3
実験手順
A mixture of 2-(R)-methylpiperazine (0.124 g, 1.1 mmol), tris(dibenzylideneacetone)dipalladium(0) (49 mg, 0.05 mmol), rac-2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (69 mg, 0.10 mmol) and sodium tert-butoxide (0.148 g, 1.5 mmol) were stirred in toluene (50 mL) under nitrogen for 15 min to give a blood red solution. 5-Bromo-1,2-dihydroacenaphthylene (0.256 g, 1.1 mmol) was added, the solution stirred under nitrogen and heated at reflux for 3 h. The mixture was cooled, diluted with dichloromethane and filtered through celite. The organic phase was washed with water, dried (MgSO4), filtered and evaporated in vacuo. The crude product was taken forward to the next step without further purification.
後処理
- customto give a blood red solution
- temperatureheated
- temperatureat reflux for 3 h
- temperatureThe mixture was cooled
- filtrationfiltered through celite
- washThe organic phase was washed with water
- dry with materialdried (MgSO4)
- filtrationfiltered
- customevaporated in vacuo
- customThe crude product was taken forward to the next step without further purification
出典と根拠
- ORDレコード
- ord-a244e5c7cab34822b5f2eb0206c39364
- 出典データセット
- uspto-grants-2008_02
- 特許番号
- US07335660B2
反応ノート
読み込み中…